Several of the genes that demonstrated a putative role as predictive biomarkers are either well-known tumor suppressors (RASSF1, XAF1, ASC/TMS1, ASPP1, DAB2IP) or DNA damage response regulators (SLFN11). This evidence concerns the gene DAB2IP and neoplasm.